Evidence map›Paper›PMID 28012935›Full record

ReviewThe Journal of allergy and clinical immunology2017

Idiopathic systemic capillary leak syndrome (Clarkson disease).

Kirk M Druey, Samir M Parikh

Open access · greenAbstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 1 synthesis or guideline pooled it, 171 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. The systemic capillary leak syndrome following COVID-19 vaccine.Human vaccines & immunotherapeutics · 2024
    Article
  17. Arteriosclerosis, thrombosis, and vascular biology · 2024
    Article
  18. Article
  19. Systemic capillary leak syndrome.Nature reviews. Disease primers · 2024
    Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kirk M DrueyLaboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Md. Electronic address: kdruey@niaid.nih.gov.
Samir M ParikhCenter for Vascular Biology Research and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
National Institutes of Health · US

Funding

Studies in the Pathogenesis of Systemic Capillary Leak SyndromeZIAAI001083 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DRUEY, KIRK M · 2009 to 2025
$11.5M
Biology of Tie2 in sepsisR01HL093234 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI PARIKH, SAMIR M · 2008 to 2017
$4.6M
Targeting the Endothelium in SepsisR01HL125275 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C, PARIKH, SAMIR M · 2014 to 2018
$4.2M
Intramural NIH HHS ZIA AI001083NHLBI NIH HHS R01 HL093234NHLBI NIH HHS R01 HL125275
6 · The paper itself

Abstract

In 1960, Dr Bayard Clarkson described a woman experiencing sporadic recurrent episodes of shock and anasarca. Plasma from an acute attack induced a shock-like syndrome when injected into rats. The enigmatic systemic capillary leak syndrome (SCLS) named for Dr Clarkson is characterized by transient and severe but reversible hemoconcentration and hypoalbuminemia caused by leakage of fluids and macromolecules into tissues. Although less than 500 cases of SCLS have been reported in the literature since 1960, the condition is probably underdiagnosed because of a lack of awareness and a high mortality without treatment. Allergists should be vigilant of this diagnosis because its presentation can resemble more common plasma leakage syndromes, including angioedema or systemic anaphylaxis. Although the precise molecular cause of SCLS remains unknown, substantial advances over the last 5 years have increased our understanding of SCLS pathogenesis.

Indexed as

Capillary Leak SyndromeAnimalsHumansIncidencePrognosisanaphylaxisangioedemaintravenous immunoglobulinVascular leak

Identifiers

PMID28012935
PMCPMC5481509
OpenAlexW2564926618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.